Analysis of the Loss of Muscle Force, Power and Motor Control to Predict the Risk of Falls in Patients With Knee OA (PowerAGING)

February 24, 2026 updated by: Istituto Ortopedico Rizzoli

Analisi Della Perdita di Forza e Potenza Muscolare e Del Degrado Del Controllo Motorio Per la Predizione Delle Cadute in Una Popolazione Affetta da Artrosi di Ginocchio

The twofold goal of this study is to understand the link between muscle power, muscle strength, and muscle control degradation with the risk of falling, and to develop a framework for the comprehensive and quantitative assessment of muscle power (and strength) in an elderly population of patients with knee osteoarthritis, who are at higher risk of falling. The main question it aims to answer is:

● Are muscle power and motor control degradation better predictors of falls than muscle strength in the aging population?

Participants will undergo:

  • Muscle force assessment on a dynamometer
  • Muscle power assessment on a dynamometer and on isntrumented stairs
  • Home-based mobility monitoring
  • Full lower limb MRI acquisition
  • Gait assessment

Study Overview

Detailed Description

Falls are a critical yet common event among the elderly, with huge societal and economic impact (reduced quality of life and high costs for the healthcare system). Experimental measures to quantify the residual muscle strength and power may provide useful information to predict the risk of falls in the elderly. Isometric and isokinetic muscle contractions, performed on a dynamometer or during functional tasks can be collected, together with electromyography (to assess muscle activity) and imaging data (to quantify and characterize muscular tissue).

Such data can be collected at different time points to monitor subjects over time, and to inform virtual representation of the human musculoskeletal system (digital twins) to identify possible motor control deficits. Moreover, this same information can be used to better characterize/assess elder individuals at risk of falling (e.g., subjects with knee osteoarthritis), to prevent future falls.

All subjects enrolled in the PowerAGING study will be followed up for 24 months (5 visits in total: M0, M6, M12, M18 and M24 follow-up). At each visit, a series of experimental tests to quantify muscle power and muscle force, as well as a home-based mobility assessment (via single inertial sensor worn for 5 consecutive days), will be performed. In addition, only at start and end, the subjects will undergo a full lower limb MRI and a gait assessment.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bologna, Italy, 40136
        • Recruiting
        • IRCCS Istituto Ortopedico Rizzoli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 65 and 80 years
  • Kellgren score II e III
  • No history of falls in the last 12 months

Exclusion Criteria:

  • Any musculoskeletal, neurological, rheumatic or tumoral diseases
  • Dementia
  • Diabetes
  • Inguinal or abdominal hernia
  • Severe Hypertension (Level 3)
  • Severe Cardio-pulmonary insufficiency
  • Diagnosis of Osteonecrosis in the lower limb joints
  • Pathologies or physical conditions incompatible with the use of magnetic resonance imaging and electrostimulation (i.e., active and passive implanted biomedical devices, epilepsy, severe venous insufficiency in the lower limbs)
  • Previous interventions or traumas to the joints of the lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Knee Osteoarthritis

Elderly patients with knee osteoarthritis, without a history of falls (in the 12 months prior to enrollment).

All subjects will be followed up for 24 months, every 6 months. Muscle force and power assessments, plus a home-based mobility monitoring, will be performed at all visits. Full lower limb MRI and a gait assessment will be performed at first and last visit.

Isokinetic dynamometry test Stair ascent/descent on instrumented stairs
Isometric dynamometry (Maximal Voluntary Isometric Contraction)
Mobility monitoring with wearable sensors
Full lower limb MRI
Motion capture, surface EMG and gorund reaction force data

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal muscle force
Time Frame: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Maximal Isometric muscle force from dynamometry test
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Muscle power
Time Frame: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Assessed on the dynamometer and during dynamic tasks
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Muscle activations
Time Frame: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
From surface EMG data collected on the dynamometer and during dynamic tasks (gait assessment and stair ascent/descent)
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Digital Mobility Outcomes
Time Frame: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Qualitative and quantiative measures of real-world mobility (e.g., gait speed, stride length)
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Musculoskeletal model predictions
Time Frame: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Estimates of muscle force and knee joint contact forces
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Muscle volumes
Time Frame: From first follow-up visit (Month 6) to last follow-up visit (Month 24)
Estimation of muscle volumes (cm3)
From first follow-up visit (Month 6) to last follow-up visit (Month 24)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisa Berti, Professor, IRCCS Istituto Ortopedico Rizzoli

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 12, 2026

Study Registration Dates

First Submitted

September 17, 2024

First Submitted That Met QC Criteria

September 20, 2024

First Posted (Actual)

September 25, 2024

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 24, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Falls Prevention

Clinical Trials on Muscle power assessment

Subscribe